ID: MRFR/HC/6064-HCR | 90 Pages | Author: Rahul Gotadki | September 2023
The RF microneedling Market Size was valued at USD 0.3 Billion in 2022. The RF microneedling industry is projected to grow from USD 0.32 Billion in 2023 to USD 0.56 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.10% during the forecast period (2023 - 2032). Rising aesthetic consciousness among consumers, increasing geriatric population, and availability of at-home RF microneedling devices are the key market drivers enhancing the market growth.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR for RF microneedling is driven by the minimally invasive technology procedure. Minimal-invasive techniques are efficient, simple, and less expensive than standard surgical approaches. It is a surgical procedure that utilizes fewer cuts or incisions. Apart from orthopedics, the advanced procedure can be broadly used for different cosmetic treatments, like microneedling. Microneedling can be achieved by piercing the epidermis to promote collagen formation. The foremost target is to heal many skin problems like scars, stretch marks, burn scars, acne, trauma, alopecia, skin discoloration, and other skin complexness. It has been noticed that multiple patients include minimally invasive surgeries to heal their skin conditions. Less sophistication, less postoperative pain, less chance of infection, the most rapid recovery, and low cost are significant factors for its increasing popularity and success.
The rising adoption of drug-loaded microneedles for delivering medicinal formulations and growing awareness regarding aesthetic medicinal treatments via social media are major factors driving market revenue growth. In addition, the rising preference of aging and geriatric patients to improve the quality of their skin and rapid advancements in microneedling systems and technology are driving the RF microneedling market revenue.
The rising demand for microneedling can also be attributed to the increasing use of microneedles for patients' transdermal administration of drugs and medicinal formulations. Drawbacks of oral drug delivery due to exposure of the drug to the acidic and enzymatic environment of the digestive system have further increased the adoption of microneedles for medical purposes. Stickers and patches pre-loaded with medicinal formulation are applied to the patient's skin to deliver the drug.
For instance, a study published by National Center for Biotechnology Information (NCBI) in 2021 suggests microneedling as an effective tool for preventing alopecia. The review surveying 22 clinical studies concluded microneedling as a favorable adjunct therapy for treating alopecia areata and androgenic alopecia. Statistics from the National Alopecia Areata Foundation (NAAF) report that approximately 6.8 million people in the US and over 145 million individuals worldwide develop alopecia areata at some point. The increasing incidence of the disorder is expected to increase the adoption of the technique over the coming years and drive revenue growth in the microneedling market.
The RF microneedling market segmentation, based on device type, includes derma-stamp, dermapen, and dermarollers. The dermapen segment dominated the market, accounting for 35% of market revenue (0.11 Billion). In developing economies, category growth is driven by increasing demand for Dermapens. Dermapen devices are widely used in dermatology clinics, and according to the American Academy of Dermatology Association, in-office microneedling treatment using dermapen equipped with RF provides more prominent results. However, dermarollers is the fastest-growing category as consumers are widely adopting it.
The RF microneedling market segmentation, based on needle material, includes silicone microneedles, metal microneedles, and glass hollow microneedles. The metal microneedle category generated the most income (70.4%). Metals have favorable physical properties, making them ideal for producing needles. However, silicone microneedle is the fastest-growing due to the increasing adoption of silicone for manufacturing needles.
The RF microneedling market segmentation, based on application, includes skin rejuvenation, acne scars, traumatic & surgical scars, and others. The skin rejuvenation segment dominated the market, accounting for 35% of market revenue (0.11 Billion). Skin rejuvenation procedures are among the most common minimally aesthetic procedures ly. However, dermarollers is the fastest-growing category due to the increasing prevalence of acne scars among the adult generation compared to others.
The RF microneedling market segmentation, based on end-user, includes hospitals and dermatology clinics. The dermatology clinics category generated the most income. Microneedling has appeared to be one of the most accessible and minimally- invasive cosmetic procedures for the treatment of dermatological conditions ranging from acne, scars, wrinkles and fine lines, stretch marks, and even hyperhidrosis. However, hospitals are the fastest-growing, providing patients with better and more advanced technological non-invasive treatment solutions.
Figure 1 RF Microneedling Market by End-User, 2022 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North America RF microneedling market will dominate, owing to an expansion in the number of cosmetic procedures performed and the presence of advanced healthcare facilities & skilled professionals driving the market in this region. Further, the US RF microneedling market held the largest market share, and the Canada RF microneedling market was the fastest-growing market in the North Amrica region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2 RF MICRONEEDLING MARKET SHARE BY REGION 2022 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe RF microneedling market accounts for the second-largest market share due to the rising number of dermatology hospitals in countries in this region and the growing adoption of microneedling procedures by aging and geriatric patients. Further, the German RF microneedling market held the largest market share, and the UK RF microneedling market was the fastest-growing market in the European region.
The Asia-Pacific RF microneedling Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to an increase in the demand for antiaging treatment and a rise in the standard of living. Moreover, China RF microneedling market held the largest market share, and India RF microneedling market was the fastest-growing market in the Asia-Pacific region.
RF Microneedling Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the RF microneedling market grow even more. Market participants are also undertaking various strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the RF microneedling industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the RF microneedling industry to benefit clients and increase the market sector. Major players in the RF microneedling market, including Lumenis, Cutera, Cynosure, Endymed Medical, Candela Medical, Dermaconcepts, Eclipse Aesthetics, and others, are attempting to increase market demand by financing R&D operations.
The energy-based medical device business Lumenis Be Ltd (Lumenis), a portfolio company of Baring Private Equity Asia, specialises in minimally invasive therapeutic solutions for aesthetic and ophthalmology applications. It produces and sells light-based technologies including medical and beauty lasers. Holmium lasers, CO2 lasers, reusable fibres, multi-wavelength lasers, laser photocoagulators, and other cosmetic devices are some of its main products. The company offers solutions to various medical environments, including aesthetic and ophthalmic procedures. In April 2019, Lumenis launched Pro+, a unique multi-application platform based on the RF's current technology. With the launch of the new RF microneedling platform, the company focuses on enhancing its credibility in the market and increasing its customer base to generate more revenue.
Cynosure Inc. designs and manufactures lasers for medical and aesthetic treatment applications, such as hair removal, leg veins, scar revision, port-wine birthmarks, facial spider veins, stretch marks, tattoos, and pigmented lesions. In March 2022, Cynosure announced a distribution partnership with Jeisys Medical Inc.'s subsidiary, headquartered in Japan. This partnership will allow the latter firm to have entire distribution rights in Japan for products of the energy-based laser portfolio of Cynosure. This is another factor expected to support
Key Companies in the RF microneedling market include
RF microneedling Industry Developments
October 2021 Cynosure announced clearance of Canada's latest radiofrequency microneedling system. The product, Potenza, has received clearance from Health Canada for providing microneedling therapies to patients suffering from dermatological issues and is the best-in-class owing to its versatility. This device can be performed in either monopolar or bipolar modes at a frequency of 1MHz or 2MHz and provides energy across large areas of skin tissue for tightening skin through soft tissue coagulation. Integration of the fusion tip to the Potenza system is a further addition to the product portfolio of the firm and is expected to improve the skin quality of customers using the microneedling device.
May 2022 Crown Laboratories acquired aesthetic-focused assets of Eclipse Medcorp, LLC. The product portfolio of the former company will expand to offer dermatological and aesthetic medicinal services and products to customers and consequently increase the customer base. Integration of the latter company with Crown Laboratories is expected to merge the product offerings of both companies to enlarge retail and commercial footprint while providing optimized services to pre-existing customers.
Report Attribute/Metric | Details |
Market Size 2022 | USD 0.3 Billion |
Market Size 2023 | USD 0.32 Billion |
Market Size 2032 | USD 0.56 Billion |
Compound Annual Growth Rate (CAGR) | 7.10% (2023-2032) |
Base Year | 2022 |
Market Forecast Period | 2023-2032 |
Historical Data | 2018- 2022 |
Market Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Material, Application, End-User and Region |
Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled | Stryker, Eclipse Aesthetics, DermaQuip, MDPen, Dermapen World, Bellus Medical, Osada, Inc, George Tiemann & Co, Delasco, MicroAire Surgical Instruments, CONMED Corporation, and Medtronic. |
Key Market Opportunities | Rising aesthetic consciousness among consumers |
Key Market Dynamics | Increasing demand of dermapens Increasing prevalence of minimally invasive procedures |
The RF microneedling market size was valued at USD 0.3 Billion in 2022.
The market is projected to grow at a CAGR of 7.10% during the forecast period, 2023-2032.
North America had the largest share of the market
The prominent players in the market are Stryker, Eclipse Aesthetics, DermaQuip, MDPen, Dermapen World, Bellus Medical, Osada, Inc, George Tiemann & Co, Delasco, MicroAire Surgical Instruments, CONMED Corporation, and Medtronic.
The dermapen category dominated the market in 2022.
Metal microneedling had the largest share of the market.
The skin rejuvenation category dominated the market in 2022.
The dermatology clinics had the largest share of the market.
Key Questions Answered
Why Choose Market Research Future?